Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04276701Active, not recruiting
Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Proportion of patients who show atherosclerotic plaque progression at 18 months. Started Mar 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04276701.